These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20416547)

  • 1. The role of azithromycin in patients with cystic fibrosis.
    Yousef AA; Jaffe A
    Paediatr Respir Rev; 2010 Jun; 11(2):108-14. PubMed ID: 20416547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR; Nahata MC
    Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects.
    Wilms EB; Touw DJ; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2012 Jul; 47(7):658-65. PubMed ID: 22684985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin for cystic fibrosis.
    Southern KW; Barker PM
    Eur Respir J; 2004 Nov; 24(5):834-8. PubMed ID: 15516680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the time come to prescribe azithromycin in cystic fibrosis patients?
    McCormack JG; Bell SC
    Intern Med J; 2005 Feb; 35(2):73-4. PubMed ID: 15705133
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection.
    Janahi IA; Abdulwahab A; Elshafie Sittana S; Bush A
    J Cyst Fibros; 2005 Mar; 4(1):71-3. PubMed ID: 15752685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.
    Florescu DF; Murphy PJ; Kalil AC
    Pulm Pharmacol Ther; 2009 Dec; 22(6):467-72. PubMed ID: 19328860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
    J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mechanisms of macrolides in cystic fibrosis.
    Equi AC; Davies JC; Painter H; Hyde S; Bush A; Geddes DM; Alton EW
    Respir Med; 2006 Apr; 100(4):687-97. PubMed ID: 16185859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring?
    Sharpton R; Condren M; O'Neal K; Lloyd A; McIntosh H
    Pulm Pharmacol Ther; 2017 Apr; 43():55-56. PubMed ID: 28219728
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.
    Catherinot E; Roux AL; Vibet MA; Bellis G; Lemonnier L; Le Roux E; Bernède-Bauduin C; Le Bourgeois M; Herrmann JL; Guillemot D; Gaillard JL;
    Eur Respir J; 2013 May; 41(5):1101-6. PubMed ID: 22936714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis.
    Taylor-Cousar JL; Jain R; Kazmerski TM; Aitken ML; West NE; Wilson A; Middleton PG; Nash EF
    J Cyst Fibros; 2021 May; 20(3):395-396. PubMed ID: 32800485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice.
    Gavilanes X; Huaux F; Meyer M; Lebecque P; Marbaix E; Lison D; Scholte B; Wallemacq P; Leal T
    J Cyst Fibros; 2009 May; 8(3):203-10. PubMed ID: 19345617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolides in cystic fibrosis.
    McArdle JR; Talwalkar JS
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy.
    Richter WJ; Nguyen JA; Wu AE; Jennings MT; Lechtzin N; Parrish NM; Psoter KJ; Cohen KA
    J Cyst Fibros; 2021 May; 20(3):555-557. PubMed ID: 32950412
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of macrophage activation states in patients with cystic fibrosis.
    Murphy BS; Bush HM; Sundareshan V; Davis C; Hagadone J; Cory TJ; Hoy H; Hayes D; Anstead MI; Feola DJ
    J Cyst Fibros; 2010 Sep; 9(5):314-22. PubMed ID: 20570573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
    Wilms EB; Touw DJ; Heijerman HG
    Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.